{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T23:56:09Z","timestamp":1793058969844,"version":"4.5.0"},"reference-count":27,"publisher":"American Medical Association (AMA)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA"],"published-print":{"date-parts":[[2018,8,21]]},"DOI":"10.1001\/jama.2017.19872","type":"journal-article","created":{"date-parts":[[2018,8,23]],"date-time":"2018-08-23T12:35:28Z","timestamp":1535027728000},"page":"706","source":"Crossref","is-referenced-by-count":156,"title":["Screening for Cervical Cancer in Primary Care"],"prefix":"10.1001","volume":"320","author":[{"given":"Jane J.","family":"Kim","sequence":"first","affiliation":[{"name":"Department of Health Policy and Management, Center for Health Decision Science, Harvard T. H. Chan School of Public Health, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily A.","family":"Burger","sequence":"additional","affiliation":[{"name":"Department of Health Policy and Management, Center for Health Decision Science, Harvard T. H. Chan School of Public Health, Boston, Massachusetts"},{"name":"Department of Health Management and Health Economics, University of Oslo, Oslo, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Regan","sequence":"additional","affiliation":[{"name":"Department of Health Policy and Management, Center for Health Decision Science, Harvard T. H. Chan School of Public Health, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Sy","sequence":"additional","affiliation":[{"name":"Department of Health Policy and Management, Center for Health Decision Science, Harvard T. H. Chan School of Public Health, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"12","key":"jus170016r1","doi-asserted-by":"publisher","first-page":"880","DOI":"10.7326\/0003-4819-156-12-201206190-00424","article-title":"Screening for cervical cancer: U.S. Preventive Services Task Force recommendation statement","volume":"156","author":"Moyer","year":"2012","journal-title":"Ann Intern Med"},{"issue":"3","key":"jus170016r2","doi-asserted-by":"publisher","first-page":"147","DOI":"10.3322\/caac.v62:3","article-title":"American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer.","volume":"62","author":"Saslow","year":"2012","journal-title":"CA Cancer J Clin"},{"issue":"5","key":"jus170016r3","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1097\/AOG.0b013e318277c92a","article-title":"ACOG Practice Bulletin Number 131: screening for cervical cancer.","volume":"120","author":"Committee on Practice Bulletins\u2014Gynecology","year":"2012","journal-title":"Obstet Gynecol"},{"issue":"2","key":"jus170016r4","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.ygyno.2014.12.022","article-title":"Use of primary high-risk human papillomavirus testing for cervical cancer screening: interim clinical guidance.","volume":"136","author":"Huh","year":"2015","journal-title":"Gynecol Oncol"},{"issue":"5","key":"jus170016r6","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1093\/aje\/kwu159","article-title":"An updated natural history model of cervical cancer: derivation of model parameters.","volume":"180","author":"Campos","year":"2014","journal-title":"Am J Epidemiol"},{"issue":"8","key":"jus170016r7","doi-asserted-by":"publisher","first-page":"589","DOI":"10.7326\/M15-0420","article-title":"Inefficiencies and high-value improvements in U.S. cervical cancer screening practice: a cost-effectiveness analysis.","volume":"163","author":"Kim","year":"2015","journal-title":"Ann Intern Med"},{"issue":"1","key":"jus170016r11","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1002\/ijc.v132.1","article-title":"A population-based study of human papillomavirus genotype prevalence in the United States: baseline measures prior to mass human papillomavirus vaccination.","volume":"132","author":"Wheeler","year":"2013","journal-title":"Int J Cancer"},{"issue":"1","key":"jus170016r12","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1158\/1055-9965.EPI-14-0775","article-title":"Human papillomavirus genotype\u2013specific prevalence across the continuum of cervical neoplasia and cancer.","volume":"24","author":"Joste","year":"2015","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"6","key":"jus170016r13","doi-asserted-by":"publisher","first-page":"djv086","DOI":"10.1093\/jnci\/djv086","article-title":"US assessment of HPV types in cancers: implications for current and 9-valent HPV vaccines.","volume":"107","author":"Saraiya","year":"2015","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"jus170016r14","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.ygyno.2006.08.053","article-title":"Diagnostic accuracy of human papillomavirus testing in primary cervical screening: a systematic review and meta-analysis of non-randomized studies.","volume":"104","author":"Koliopoulos","year":"2007","journal-title":"Gynecol Oncol"},{"issue":"3","key":"jus170016r15","doi-asserted-by":"publisher","first-page":"184.e1","DOI":"10.1016\/j.ajog.2012.11.020","article-title":"Comparison of cervical cancer screening strategies incorporating different combinations of cytology, HPV testing, and genotyping for HPV 16\/18: results from the ATHENA HPV study.","volume":"208","author":"Cox","year":"2013","journal-title":"Am J Obstet Gynecol"},{"key":"jus170016r16","doi-asserted-by":"publisher","first-page":"F88","DOI":"10.1016\/j.vaccine.2012.06.095","article-title":"Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer.","volume":"30","author":"Arbyn","year":"2012","journal-title":"Vaccine"},{"issue":"7","key":"jus170016r17","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/S1470-2045(06)70731-8","article-title":"Human papillomavirus testing and liquid-based cytology in primary screening of women younger than 35 years: results at recruitment for a randomised controlled trial.","volume":"7","author":"Ronco","year":"2006","journal-title":"Lancet Oncol"},{"issue":"11","key":"jus170016r18","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1093\/jnci\/djj209","article-title":"Human papillomavirus testing and liquid-based cytology: results at recruitment from the New Technologies for Cervical Cancer randomized controlled trial.","volume":"98","author":"Ronco","year":"2006","journal-title":"J Natl Cancer Inst"},{"issue":"5","key":"jus170016r19","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1158\/1055-9965.EPI-13-0973","article-title":"A population-based evaluation of cervical screening in the United States: 2008-2011.","volume":"23","author":"Cuzick","year":"2014","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"12","key":"jus170016r20","doi-asserted-by":"publisher","first-page":"2854","DOI":"10.1002\/ijc.v136.12","article-title":"Human papillomavirus testing 2007-2012: co-testing and triage utilization and impact on subsequent clinical management.","volume":"136","author":"Cuzick","year":"2015","journal-title":"Int J Cancer"},{"issue":"3","key":"jus170016r21","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1016\/j.ygyno.2013.12.037","article-title":"Cervical excisional treatment of young women: a population-based study.","volume":"132","author":"Kinney","year":"2014","journal-title":"Gynecol Oncol"},{"issue":"2","key":"jus170016r22","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1002\/ijc.v140.2","article-title":"HPV for cervical cancer screening (HPV FOCAL): complete round 1 results of a randomized trial comparing HPV-based primary screening to liquid-based cytology for cervical cancer.","volume":"140","author":"Ogilvie","year":"2017","journal-title":"Int J Cancer"},{"issue":"5","key":"jus170016r23","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1097\/LGT.0b013e318287d329","article-title":"2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors.","volume":"17","author":"Massad","year":"2013","journal-title":"J Low Genit Tract Dis"},{"issue":"2","key":"jus170016r24","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1097\/LGT.0b013e3182616241","article-title":"Screening for cervical cancer: a modeling study for the US Preventive Services Task Force.","volume":"17","author":"Kulasingam","year":"2013","journal-title":"J Low Genit Tract Dis"},{"issue":"6","key":"jus170016r25","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1002\/cncr.30507","article-title":"Hysterectomy-corrected cervical cancer mortality rates reveal a larger racial disparity in the United States.","volume":"123","author":"Beavis","year":"2017","journal-title":"Cancer"},{"issue":"13","key":"jus170016r26","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.1002\/cncr.28548","article-title":"Increased age and race-specific incidence of cervical cancer after correction for hysterectomy prevalence in the United States from 2000 to 2009.","volume":"120","author":"Rositch","year":"2014","journal-title":"Cancer"},{"issue":"5","key":"jus170016r27","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1002\/cncy.21544","article-title":"Comparison of cervical cancer screening results among 256,648 women in multiple clinical practices.","volume":"123","author":"Blatt","year":"2015","journal-title":"Cancer Cytopathol"},{"key":"jus170016r5","volume-title":"Screening for Cervical Cancer With High-Risk Human Papillomavirus Testing: A Systematic Evidence Review for the U.S. Preventive Services Task Force: Evidence Synthesis No. 158","author":"Melnikow","year":"2017"},{"key":"jus170016r8","unstructured":"National Center for Health Statistics (NCHS). 2010 National Hospital Discharge Survey (NHDS) public use micro-data file and documentation. NCHS website. https:\/\/www.cdc.gov\/nchs\/nhds\/nhds_questionnaires.htm. 2012. Accessed January 31, 2017."},{"key":"jus170016r9","unstructured":"University of California Berkeley. Berkeley Mortality Database. http:\/\/www.demog.berkeley.edu\/~bmd. Accessed August 2, 2016."},{"key":"jus170016r10","unstructured":"National Cancer Institute. Surveillance, Epidemiology, End Results (SEER) Cancer Statistics Review, 1975-2013. https:\/\/seer.cancer.gov\/archive\/csr\/1975_2013\/. September 12, 2016. Accessed January 31, 2017."}],"container-title":["JAMA"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/fullarticle\/2697702","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,8]],"date-time":"2020-11-08T00:13:01Z","timestamp":1604794381000},"score":1,"resource":{"primary":{"URL":"http:\/\/jama.jamanetwork.com\/article.aspx?doi=10.1001\/jama.2017.19872"}},"subtitle":["A Decision Analysis for the US Preventive Services Task Force"],"short-title":[],"issued":{"date-parts":[[2018,8,21]]},"references-count":27,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2018,8,21]]}},"URL":"https:\/\/doi.org\/10.1001\/jama.2017.19872","relation":{},"ISSN":["0098-7484"],"issn-type":[{"value":"0098-7484","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8,21]]}}}